About 1 result found for searched term "936694-12-1" (0.121 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M30936 | Glesatinib | TAM Receptor |
| MGCD265 | ||
| Glesatinib (MGCD265) is an orally active, potent MET/SMO dual inhibitor. Glesatinib, a tyrosine kinase inhibitor, antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
